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Abstract
Introduction: Autophagy is an adaptive response to extracellular and intracellular stress by which cytoplasmic components
and organelles, including damaged mitochondria, are degraded to promote cell survival and restore cell homeostasis.
Certain genes involved in autophagy confer susceptibility to Crohn’s disease. Reactive oxygen species and pro-inflammatory
cytokines such as tumor necrosis factor a (TNFa), both of which are increased during active inflammatory bowel disease,
promote cellular injury and autophagy via mitochondrial damage. Prohibitin (PHB), which plays a role in maintaining normal
mitochondrial respiratory function, is decreased during active inflammatory bowel disease. Restoration of colonic epithelial
PHB expression protects mice from experimental colitis and combats oxidative stress. In this study, we investigated the
potential role of PHB in modulating mitochondrial stress-related autophagy in intestinal epithelial cells.
Methods: We measured autophagy activation in response to knockdown of PHB expression by RNA interference in Caco2-
BBE and HCT116 WT and p53 null cells. The effect of exogenous PHB expression on TNFa- and IFNc-induced autophagy was
assessed. Autophagy was inhibited using Bafilomycin A1 or siATG16L1 during PHB knockdown and the affect on intracellular
oxidative stress, mitochondrial membrane potential, and cell viability were determined. The requirement of intracellular ROS
in siPHB-induced autophagy was assessed using the ROS scavenger N-acetyl-L-cysteine.
Results: TNFa and IFNc-induced autophagy inversely correlated with PHB protein expression. Exogenous PHB expression
reduced basal autophagy and TNFa-induced autophagy. Gene silencing of PHB in epithelial cells induces mitochondrial
autophagy via increased intracellular ROS. Inhibition of autophagy during PHB knockdown exacerbates mitochondrial
depolarization and reduces cell viability.
Conclusions: Decreased PHB levels coupled with dysfunctional autophagy renders intestinal epithelial cells susceptible to
mitochondrial damage and cytotoxicity. Repletion of PHB may represent a therapeutic approach to combat oxidant and
cytokine-induced mitochondrial damage in diseases such as inflammatory bowel disease.
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Introduction
Autophagy is an evolutionarily conserved catabolic pathway
that degrades cytoplasmic components such as long-lived proteins,
macromolecules and damaged organelles including the endoplas-
mic reticulum and mitochondria through lysosomal degradation
[1,2,3]. Autophagy is an adaptive response to extracellular stress,
such as starvation, or intracellular stress, including the accumu-
lation of misfolded proteins, damaged organelles, or the invasion
of microorganisms, intended to promote cell survival and restore
cell homeostasis [4]. Either apoptosis or autophagic cell death can
be initiated in irreversibly damaged cells [5]. Malfunctioning
autophagy has been associated with multiple diseases such as
cancer, neurodegeneration, autoimmune diseases and inflamma-
tory diseases, including inflammatory bowel disease (IBD) [6].
The two common, but disparate, forms of IBD, Crohn’s disease
and ulcerative colitis, share related characteristics such as mucosal
damage and diarrhea but have distinguishing clinical features. The
etiopathogenesis of IBD remains unknown but is thought to
involve a combination of genetic and non-genetic risk factors that
regulate mucosal immune response, mucosal barrier function, and
response to microbial factors [7]. Multiple epithelial molecules
have been identified as mediators of IBD pathogenesis including
those that control epithelial homeostasis [8]. Genome-wide
association studies and meta-analysis have identified the autoph-
agy genes ATG16L1, IRGM, and LRRK2 as candidate loci
involved in genetic susceptibility to Crohn’s disease [9,10,11,12].
Mutation or deletion of ATG16L1 results in increased pro-
inflammatory cytokine production, increased susceptibility to
experimental colitis, and reduced capability to eradicate invading
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intestinal inflammation [13,14,15].
Multiple studies have reported mitochondrial dysfunction in
Crohn’s disease and ulcerative colitis [16,17,18,19] as well as the
dextran sodium sulfate and 2,4,6-trinitrobenzene sulfonic acid
models of colitis [20,21]. Mitochondria are important regulators
of autophagy and apoptosis. During normal function of the
mitochondrial respiratory chain, reactive oxygen species (ROS),
which are partially reduced oxygen species such as superoxide
radical (O2
2), hydrogen peroxide (H2O2), hydroxyl radical
(?OH), and peroxynitrate (NOO
2), are generated at low levels.
Production of ROS is increased when mitochondria are damaged
[22]. IBD is associated with increased ROS and decreased
antioxidant enzymes in the intestinal mucosa [23,24,25,26]. It is
widely accepted that ROS produced as a by-product of
respiration as well as exogenous ROS can induce autophagy
via mitochondrial damage [27,28]. Mitochondria are the main
source of ROS for regulation of autophagy [29]. In fact,
exogenous ROS and the proinflammatory cytokine tumor
necrosis factor a (TNFa), both of which are increased during
IBD, promote cellular injury and autophagy via mitochondrial
ROS generation [29,30,31]. Defects in autophagy result in the
accumulation of intracellular ROS and deformed mitochondria
[14,32].
Prohibitin 1 (PHB) is an evolutionarily conserved, multifunc-
tional 32 kDa protein implicated in cellular processes including
the regulation of proliferation, apoptosis, and transcription
[33,34,35,36]. PHB is predominantly localized to the mitochon-
dria in intestinal epithelial cells [37] and multiple studies have
shown that PHB plays a role in maintaining normal mitochon-
drial function and morphology (reviewed in [38]). It has been
shown that PHB interacts with complex I and subunits of
cytochrome c oxidase of the respiratory chain and regulates their
assembly [39,40]. Loss of PHB in mitochondria impairs function
of the mitochondrial respiratory chain [39,40]. One obvious
effect of respiratory chain dysfunction is increased oxidant
production leading to oxidative stress, which can cause
alterations in mitochondrial morphology and membrane poten-
tial [29].
Expression of PHB is decreased in mucosal biopsies from
ulcerative colitis and Crohn’s disease afflicted patients and in
animal models of colitis [37,41]. Pro-inflammatory cytokines such
as TNFa and oxidative stress induced by exogenous H2O2
decrease expression of intestinal epithelial PHB in vivo and in vitro
[37,42]. Restoration of colonic epithelial PHB expression using
genetic manipulation (villin-PHB transgenic mice) or therapeutic
delivery to the colon via nanoparticle or adenovirus protected
mice from experimental colitis [43,44]. Our recent data suggest
that epithelial PHB sustains anti-oxidant expression [44] and has
anti-inflammatory properties such as reducing TNFa-stimulated
NF-kB activation [42]. This is in agreement with emerging data
that suggest a role of PHB in combating oxidative stress in multiple
cells types [39,40,45,46]. In this study, we investigated the
potential role of PHB in modulating mitochondrial stress-related
autophagy in intestinal epithelial cells. Here, we show that TNFa
and IFNc-induced autophagy inversely correlates with PHB
protein expression and that gene silencing of PHB induces
mitochondrial autophagy via increased intracellular ROS. Inhibi-
tion of autophagy during PHB knockdown exacerbates mitochon-
drial depolarization and reduces cell viability. These data suggest
that decreased PHB levels coupled with dysfunctional autophagy
renders intestinal epithelial cells susceptible to mitochondrial ROS
and cytotoxicity.
Results
PHB protein expression inversely correlates with
cytokine-induced autophagy in cultured colonic
epithelial cells
Our previous studies showed that TNFa reduces expression of
PHB in intestinal epithelial cells in vivo and in vitro [42]. Pro-
inflammatory cytokines such as TNFa and IFNc have been shown
to induce autophagy in human intestinal epithelial cell lines
[31,47]. Confluent monolayers of Caco2-BBE cells were treated
with 10 ng/ml TNFa or 50 ng/ml IFNc alone or in combination
for 18 hours. As expected, TNFa and IFNc increased two
biochemical signs of autophagy: the conversion of LC3-I to
LC3-II, indicated by normalizing LC3-II to LC3-I protein levels,
and increased beclin-1 protein expression (Figure 1A and 1B)
[27,48]. Conversely, PHB protein levels in the same samples were
decreased by TNFa and IFNc (Figure 1A and 1B). The effect of
TNFa and IFNc given in combination reflected that of cells
treated with either cytokine alone and therefore, we did not pursue
the effects of these cytokines in combination. It is widely accepted
that the tumor suppressor p53 regulates autophagy [49]. Since
Caco2-BBE cells have mutated p53 [50], we assessed the
involvement of p53 in autophagy induction by TNFa and IFNc
in wild-type (WT) and p53 null HCT116 colonic epithelial cells.
HCT116 cells, including p53 null cells [51], also showed the
conversion of LC3-I to LC3-II and increased beclin-1 protein
expression suggesting that the effect of TNFa and IFNc to increase
autophagy and decrease PHB protein expression is independent of
p53 signaling (Figure 1C and 1D).
Exogenous PHB expression reduces basal autophagy and
TNFa-induced autophagy in intestinal epithelial cells
Since PHB expression inversely correlated with the induction of
autophagy in colonic epithelial cells, we determined whether
exogenous PHB expression could affect autophagy. Caco2-BBE
cells stably overexpressing GFP-tagged PHB (pEGFPN1-PHB)
show decreased LC3-II conversion from LC3-I and reduced
beclin-1 protein expression (Figure 2A and 2B), suggesting a
reduction in basal autophagy. Treatment with TNFa or IFNc
increased LC3-II and beclin-1 protein abundance in empty vector
expressing cells (Figure 2A and 2B), reflecting the same response as
WT Caco2-BBEs in Figure 1A. PHB overexpressing cells showed
decreased TNFa-induced LC3-I conversion to LC3-II and beclin-
1 protein expression compared to vector-transfected cells, whereas
PHB overexpression did not affect IFNc-induced LC3-II or
beclin-1 protein expression (Figure 2A and 2B). Since PHB
overexpression did not decrease IFNc-induced autophagy, this
would suggest that the IFNc autophagy pathway is distinct from
that of TNFa. An antibody specific to GFP was used to assess
protein expression of GFP-PHB and GFP in PHB and vector
overexpressing cells, respectively.
Knockdown of PHB induces autophagy
Since PHB protein expression inversely correlated with TNFa-
and IFNc-induced autophagy in Caco2-BBE cells, we next
determined whether knockdown of PHB expression could induce
autophagy. Caco2-BBE cells transfected with siPHB showed
conversion of LC3-I into LC3-II (Figure 3A) as well as increased
beclin-1 protein expression (Figure 3B) compared to cells
transfected with a negative control siRNA (siNeg ctl). PHB
knockdown stimulated the redristribution of GFP-LC3 fusion
protein from a diffuse signal to cytoplasmic puncta indicative of
autophagosomes (Figure 3C). The mitochondrial stress proteins
Prohibitin Modulation of Autophagy
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Western blot upon PHB knockdown suggesting that inhibition of
PHB does not induce the mitochondrial unfolded protein response
(Figure S1). The efficiency of siRNA knockdown was validated by
western blot (Figure 3A). Protein expression of PHB was reduced
,80% 96 hours after transfection.
The effect of PHB knockdown in Caco2-BBE cells was
corroborated in HCT116 cells. Knockdown of PHB induced the
conversion of LC3-I to LC3-II, increased beclin-1 protein
expression (Figure 4A and 4B) and increased the formation of
cytoplasmic puncta by the GFP-LC3 fusion protein (Figure 4C).
Although knockdown of PHB in HCT116 cells (approximately
50% reduction compared to control; Figure 4A) was not as strong
as in Caco2-BBE cells, the results on autophagy were similar to
that in Caco2-BBE cells. p53 inhibition, including p53 knockout
by homologous recombination, initially induces autophagy by ER
stress followed by mitophagy (autophagy of mitochrondria) [52].
To determine whether the induction of autophagy by PHB
Figure 1. PHB protein levels inversely correlate with cytokine-induced autophagy in cultured colonic epithelial cells. (A)
Representative Western blots showing LC3I/LC3II, Beclin-1, PHB or b-actin (loading control) expression in Caco2-BBE cells treated with 10 ng/ml TNFa
or 50 ng/ml IFNc alone or in combination for 18 hours. (B) Histograms show mean 6 SEM relative to no treatment control Caco2-BBE cells. *P,0.05
vs. no tx; n=3. (C) Representative Western blots showing LC3I/LC3II, Beclin-1, PHB or b-actin (loading control) expression in HCT116 cells treated with
10 ng/ml TNFa or 50 ng/ml IFNc alone or in combination for 18 hours. (D) Histograms show mean 6 SEM relative to no treatment control HCT116
cells. *P,0.05 vs. no tx; n=3.
doi:10.1371/journal.pone.0031231.g001
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assessed in p53
2/2 HCT116 cells transfected with siPHB. p53
2/2
cells showed increased LC3-II and GFP-LC3 puncta formation
compared to WT cells (Figure 4A and 4C) as previously described
[52]. p53
2/2 cells also exhibited increased beclin-1 protein
expression compared to WT cells (Figure 4A and 4B). Knockdown
of PHB caused a further increase in autophagy in p53
2/2 cells,
suggesting that siPHB-mediated autophagy is independent of p53
signaling. ER stress is not further increased in p53
2/2 cells upon
PHB knockdown (Figure S2).
PHB knockdown increases intracellular reactive oxygen
species and induces mitochondrial depolarization
Autophagy is induced by multiple stimuli including damage to
organelles such as the endoplasmic reticulum and mitochondria.
Given that the predominant subcellular localization of PHB is in
the mitochondria in most cell types studied to date, emerging
data suggest that PHB plays a role in stabilizing components of
the electron transport chain [38]. Depletion of PHB function has
been shown to cause electron transport chain disruption and
increased intracellular oxidative stress [39,40]. As an indicator of
intracellular ROS, Caco2-BBE cells transfected with siPHB or
siNeg ctl were loaded with the oxidation-sensitive dye H2DCF-
DA and assayed for DCF fluorescence 10, 20 and 30 minutes
after loading using a plate reader. PHB knockdown caused a
30% increase in intracellular ROS compared to control cells at
each time point measured (Figure 5A; No tx). Recent data has
shown that specific gene mutations or deficiency in autophagy is
linked to susceptibility to inflammatory bowel disease
[9,10,11,12]. To mimic this situation, autophagy was inhibited
using 100 nM Baf A for 12 hours or RNAi against the
autophagy gene ATG16L1. Efficiency of ATG16L1 knockdown
is shown in Figure 5D. Inhibition of autophagy increased
intracellular ROS in both control and siPHB-transfected cells;
the magnitude, however, was significantly greater in siPHB-
transfected cells at all time points (Figure 5A; Baf A and
siATG16L). Caco2-BBE cells stably overexpressing PHB show
reduced DCF fluorescence compared to vector-transfected cells
(Figure 5B; No tx). In the setting of PHB overexpression coupled
with autophagy inhibition (Baf A or siATG16L1), ROS levels are
not further increased and in fact are decreased during loss of
ATG16L1. These results suggest that PHB expression regulates
intracellular ROS and that autophagy prevents the accumulation
of ROS.
To determine whether the increase in intracellular ROS is
associated with altered mitochondrial integrity, mitochondrial
membrane potential (MMP) was assessed using JC-1 dye. As
shown in Figure 5C, the percentage of Caco2-BBE cells testing
positive for depolarized mitochondria increased from ,29% of
control cells to ,41% of cells with PHB knockdown in the absence
of inhibitors of autophagy (No tx, left panels), suggesting that loss
of PHB negatively affects mitochondrial integrity. Inhibition of
autophagy using Baf A or RNAi against ATG16L1 increased the
percentage of control cells (Figure 5C, top panels) with
mitochondrial membrane depolarization from ,29% to ,36%
(Baf A) and ,51% (siATG16L1). In cells with silenced PHB,
treatment with Baf A increased the percentage of cells with
mitochondrial membrane depolarization from ,41% to ,51%
and siATG16L1 increased the percentage to ,56% (Figure 5C,
bottom panels). These results suggest that loss of PHB function
induces mitochondrial dysfunction and that inhibition of autoph-
agy increases the number of cells with altered mitochondrial
function within the cell population.
Figure 2. Exogenous PHB expression reduces basal autophagy
and TNFa-induced autophagy in intestinal epithelial cells. (A)
Representative Western blots of 3 independent experiments showing
LC3I/LC3II, Beclin-1, GFP-PHB, GFP or b-actin (loading control)
expression in Caco2-BBE cells transfected with either pEGFPN1
expression vector (V) or pEGFPN1-PHB (P) and treated with 10 ng/ml
TNFa or 50 ng/ml IFNc for 18 hours. (B) Histograms show mean 6 SEM
relative to no treatment control cells. *P,0.05 vs. no tx; n=3.
doi:10.1371/journal.pone.0031231.g002
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Cell cytoxicity was assessed by measuring the release of lactate
dehydrogenase. Across all treatments, Caco2-BBE cells transfect-
ed with siPHB were less viable than control cells (Figure 6A).
Inhibition of autophagy using Baf A further decreased viability in
siPHB-transfected cells compared to control cells. RNAi against
the autophagy gene ATG16L1 reduced viability in both siPHB
and siNeg ctl cells, but the effect was greater in siPHB cells.
These results suggest that PHB knockdown reduces cell viability
and that autophagy acts to promote cell survival. The effect of
PHB knockdown to reduce cell viability was exacerbated by the
pro-inflammatory cytokines TNFa and IFNc (Figure 6A). IFNc
reduced viability in cells with PHB knockdown versus control
cells, but in combination with autophagy inhibition IFNc had no
further effect than inhibition of autophagy alone. In contrast,
TNFa dramatically reduced cell viability in siPHB-transfected
cells with inhibited autophagy (Figure 6A), supporting the
concept that the IFNc autophagy pathway is distinct from that
of TNFa. These results suggest that autophagy is important for
cell survival when TNFa levels are high and when PHB
Figure 3. Knockdown of PHB induces autophagy. Markers of autophagy were assessed in Caco2-BBE cells transfected with either siNeg ctl or
siPHB for 96 hours. (A) Representative Western blots showing LC3I/LC3II, Beclin-1 or b-actin (loading control) expression. PHB protein levels were
assessed to determine efficiency of knockdown. (B) Histograms show mean 6 SEM. **P,0.01 vs. siNeg ctl; n=3 (C) Fluorescent micrographs of cells
expressing pSelect-GFP-LC3 (green) and stained with DAPI (blue) to visualize nuclei. Quantification of cells with punctuate GFP-LC3. Histograms show
mean 6 SEM. **P,0.01 vs. siNeg ctl, n $ 5 fields with .50 cells/field.
doi:10.1371/journal.pone.0031231.g003
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inflammation.
To determine whether cell death induced by PHB knockdown
involves apoptosis, cleaved Caspase-3 protein expression and
TUNEL staining were determined. Levels of cleaved Caspase-3
protein were increased during PHB knockdown and further
increased by autophagy inhibition and TNFa treatment
(Figure 6B). The percent TUNEL positive cells was increased
during PHB knockdown and further increased by autophagy
inhibition and TNFa treatment (Figure 6C), suggesting that cell
death is at least partially due to apoptosis. To determine whether
increased intracellular ROS is associated with increased cell death
during autophagy inhibition and TNFa treatment, DCF fluores-
cence was measured in cells transfected with or without siPHB and
treated with TNFa and autophagy inhibitors. Figure 6D shows
that knockdown of PHB increased ROS levels for all treatment
groups compared to control. TNFa treatment during inhibition of
autophagy causes a further increase in intracellular ROS, which is
further exaggerated in cells with PHB knockdown.
Treatment with NAC, a ROS scavenger, prevents siPHB-
induced mitochondrial stress-related autophagy
To determine whether mitochondria are indeed recycled during
siPHB-induced autophagy, siPHB and GFP-LC3 co-transfected
Figure 4. Knockdown of PHB using siRNA induces autophagy independently of p53 in HCT116 cells. Markers of autophagy were
assessed in HCT116 cells transfected with either siNeg ctl or siPHB for 96 hours. (A) Representative Western blot showing LC3I/LC3II , Beclin-1 or b-
actin (loading control) expression. PHB protein levels were assessed to determine efficiency of knockdown. (B) Histograms show mean 6 SEM relative
to no treatment control cells. *P,0.05 vs. siNeg ctl; n=3. (C) Fluorescent micrographs of cells expressing pSelect-GFP-LC3 (green) and stained with
DAPI (blue) to visualize nuclei. Quantification of cells with punctuate GFP-LC3. Histograms show mean 6 SEM. *P,0.05 vs. siNeg ctl, n=5 fields with
.50 cells/field.
doi:10.1371/journal.pone.0031231.g004
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(red fluorescence). Laser scanning confocal microscopy revealed
significant co-localization of mitochondria with GFP autophago-
somes in cells with silenced PHB compared to control cells
(Figure 7A, upper panels versus middle panels), suggesting
mitophagy. To determine whether increased intracellular ROS
is the mechanism by which PHB knockdown induces autophagy,
cells were treated with 1.0 mM NAC for 24 hours prior to
collection. The addition of NAC prevented the increase in GFP-
LC3 puncta, indicative of autophagosomes, by PHB knockdown
and prevented the co-localization of GFP-LC3 with mitochondria
(Figure 7A, lower panels).
Caco2-BBE cells were transfected with siPHB for 96 hours and
treated with 1.0 mM or 10.0 mM NAC for 24 hours starting at
72 hours post-transfection. PHB knockdown stimulated the
conversion of LC3I to LC3II compared to siNeg ctl cells
Figure 5. PHB knockdown increases intracellular reactive oxygen species and induces mitochondrial depolarization. (A) DCF
fluorescence was measured in Caco2-BBE cells transfected with siRNA for 96 hours and treated as indicated for 18 hours. Cells were loaded with
DCFH-DA for 10 minutes and fluorescence was determined 10, 20 and 30 minutes after loading using a plate reader to assess intracellular ROS levels.
**P,0.01, ***P,0.001; n=16 from two separate experiments. (B) DCF fluorescence was measured in Caco2-BBE cells stably transfected with pEGFPN1
expression vector or pEGFPN1-PHB as in (A). ***P,0.001; n=8. (C) Mitochondrial membrane depolarization was measured in Caco2-BBE cells stained
with JC-1 dye as demonstrated by a shift from red (intact MMP) to green (depolarized) fluorescence detected by flow cytometry. The data shown are
a representative result from one of three experiments. (D) ATG16L1 protein levels were assessed by Westen blotting to determine efficiency of
knockdown.
doi:10.1371/journal.pone.0031231.g005
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addition of NAC prevented siPHB-induced conversion of LC3I to
LC3II in a dose-dependent manner (Figure 7B). These results
suggest that silencing of PHB expression increases intracellular
oxidative stress, which subsequently induces mitophagy. DCF
fluorescence was measured to ensure that NAC treatment reduced
intracellar ROS (Figure 7C).
Discussion
In addition to the emerging role of autophagy in controlling
bacterial invasion [15,53,54], autophagy recycling represents the
final tier of mitochondrial quality control. Multiple studies have
reported mitochondrial dysfunction in Crohn’s disease and
ulcerative colitis [16,17,18,19] and mouse models of colitis
[20,21]. Mitochondria are important regulators of autophagy
and apoptosis. Exogenous ROS and cytokines such as TNFa, both
of which are increased during IBD, promote cellular injury and
autophagy via mitochondrial ROS generation [29,30,31]. We
show here that PHB modulates autophagy in intestinal and colonic
epithelial cells. Reduced PHB protein expression by RNA
interference induces autophagy of mitochondria and treatment
with NAC, a ROS scavenger, prevents siPHB-induced autophagy.
These results suggest that loss of PHB expression induces
Figure 6. Silencing of PHB expression reduces cell viability. (A) Cytotoxicity as measured by LDH test of Caco2-BBE cells transfected with
siRNA for 96 hours and treated as indicated for 18 hours. *P,0.05, **P,0.01, ***P,0.001; ****P,0.0001 vs. all other treatments; n=3 experiments
run in quadruplicate. (B) Representative Western blot showing cleaved Caspase-3 or b-actin (loading control) expression. (C) Percent TUNEL-positive
Caco2-BBE cells. A minimum of 5 fields were counted for each treatment. *P,0.05. (D) DCF fluorescence was measured in Caco2-BBE cells transfected
with siRNA for 96 hours and treated as indicated for 18 hours. Cells were loaded with DCFH-DA for 10 minutes and fluorescence was determined
10 minutes after loading. *P,0.05; n=8.
doi:10.1371/journal.pone.0031231.g006
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induces mitochondrial membrane depolarization, suggesting
mitochondrial damage, and increased intracellular ROS which is
likely generated via dysfunctional respiration, all of which are
exacerbated by inhibition of autophagy. Therefore, autophagy
plays a protective role during conditions when PHB expression is
low in intestinal epithelial cells.
We have previously shown that expression of PHB protein is
reduced in mucosa during active inflammatory bowel disease and
in Caco2-BBE cells treated with TNFa or exogenous oxidants
[37,42]. It has been demonstrated that TNFa and IFNc induce
autophagy in intestinal epithelium [31,55] and that autophagy can
attenuate inflammatory responses, thereby maintaining intestinal
homeostasis [56]. PHB protein levels inversely correlated with
TNFa and IFNc-induced autophagy in Caco2-BBE and HCT116
cells. Furthermore, exogenous PHB expression reduced basal
autophagy and TNFa-induced autophagy, suggesting that expres-
sion of PHB modulates the cellular autophagic response. One
potential mechanism whereby PHB regulates beclin-1, the first
mammalian gene shown to induce autophagy, is through the
transcription factor E2F1. The beclin-1 promoter contains a
putative E2F1 binding site [57] and PHB has been shown to
regulate E2F1 activity [35]. Future studies will investigate this
possibility. It is compelling to speculate that reduced PHB
expression coupled with dysfunctional autophagy, an emerging
susceptibility trait in Crohn’s disease [13,14,15], could render
epithelial cells unable to recycle damaged mitochondria and thus
they succumb to cell death. It has been shown that when less than
66% of the mitochondria within a cell are damaged, autophagy
predominates to restore cell homeostasis, while apoptosis is
triggered when the percentage increases to involve most of the
mitochondrial population [58,59]. The likely reason cell viability is
decreased during PHB knockdown coupled with autophagy
inhibition or TNFa treatment is that the threshold of damaged
mitochondria exceeds the capacity of the cell.
Our finding that decreased PHB levels coupled with inhibited
autophagy increased cell death has important clinical implications.
Patients with inflammatory bowel disease exhibit decreased
expression of PHB in intestinal epithelial cells [37,41]. Dysfuntion
in autophagy genes such as ATG16L1, IRGM, and LRRK2, are
emerging as potential susceptibility traits in patients with
inflammatory bowel disease [9,10,11,12]. We speculate that
decreased expression of PHB during active inflammatory bowel
disease is a signal to the epithelial cell that there is inflammatory
stress and that autophagy is subsequently induced to maintain cell
viability and return homeostasis. Thus, these findings support an
important role of autophagy in intestinal health and lend further
insight into the mechanisms of dysfunctional autophagy via PHB
in inflammatory bowel diseases. In the setting of PHB overex-
pression coupled with autophagy inhibition, ROS levels were not
further increased and in fact are decreased during loss of
ATG16L1. These data support the therapeutic concept of
repletion of PHB levels in the setting of dysfunctional autophagy.
Basal autophagy was reduced by PHB overexpression in Caco2-
BBE cells. We have shown previously that exogenous PHB
expression in Caco2-BBE cells induced the expression of
glutathione-S-transferase p, an antioxidant enzyme that catalyzes
the conjugation of electrophiles to GSH [37], and modulates the
activity of nuclear factor erythroid 2-related factor 2 (Nrf2), a
transcriptional regulator of antioxidant response [42]. PHB
overexpression may reduce basal autophagy through an increased
antioxidant response on ROS production during normal physio-
logical respiration. This issue warrants further investigation.
Although PHB protein levels inversely correlated with IFNc-
induced autophagy, overexpression of PHB in Caco2-BBE cells
did not affect IFNc-induced autophagy. This is in contrast to the
response to TNFa. NF-kB, a major downstream signaling
Figure 7. Treatment with NAC, a ROS scavenger, prevents
siPHB-induced mitochondrial stress-related autophagy. (A)
Caco2-BBE cells were co-transfected with siPHB or siNeg Ctl and GFP-
LC3 (green fluorescence) and incubated with MitoTracker dye (red
fluorescence, mitochondria). Cells were incubated with 1.0 mM NAC for
24 hours prior to collection. Merged confocal images demonstrate
mitophagy (yellow fluorescence). Cells were stained with DAPI to
visualize nuclei (blue). Bar=10 mM. (B) Representative Western blot
showing LC3I/LC3II or b-actin (loading control) expression. The data
shown are a representative result from one of three experiments. (C)
DCF fluorescence was measured in Caco2-BBE cells transfected with
siPHB for 96 hours and treated with NAC for 18 hours. Cells were
loaded with DCFH-DA for 10 minutes and fluorescence was determined
20 minutes after loading using a plate reader to assess intracellular ROS
levels. **P,0.01, n=8.
doi:10.1371/journal.pone.0031231.g007
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[60]. Our previous work demonstrated that exogenous PHB
expression reduced basal and TNFa-stimulated NF-kB activation
[42]. It is possible that this effect on NF-kB reduces TNFa-
induced autophagy as compared to IFNc since IFNc is not a
major activator of NF-kB. Furthermore, TNFa promotes
autophagy via mitochondrial ROS generation [31]. TNFa
treatment during inhibition of autophagy exacerbated intracellular
ROS levels in cells with knockdown of PHB. Since PHB
overexpression did not decrease IFNc induced autophagy, this
would suggest that the IFNc autophagy pathway is distinct from
that of TNFa. Exogenous PHB expression can likely prevent
TNFa-induced autophagy since PHB overexpression reduces
ROS generation. The mechanism whereby PHB overexpression
dampens basal and TNFa-induced, but not IFNc-induced,
autophagy requires further investigation.
It is widely accepted that the tumor suppressor p53 regulates
autophagy depending upon is subcellular localization [49].
Normal levels of p53 maintain a tonic inhibition of autophagy;
autophagy is induced via a reduction in cytoplasmic p53 levels
[61]. p53 can activate genes that induce autophagy including
damage-regulated autophagy modulator (DRAM) and sestrins 1
and 2 [62]. Since Caco2-BBE cells have mutated p53, we included
WT and p53 null HCT116 colonic epithelial cells to assess the
involvement of p53 in autophagy mediated by PHB knockdown.
PHB levels inversely correlated with TNFa- or IFNc-induced
autophagy regardless of p53 status. As previously described [52],
p53
2/2 HCT116 cells exhibited increased autophagy compared
to WT cells. p53 knockout initially induces autophagy by ER stress
followed by mitophagy [52]. Knockdown of PHB caused a further
increase in autophagy in p53
2/2 cells, suggesting that autophagy
mediated by PHB knockdown is independent of p53. ER stress
markers indicate that ER stress was not further increased upon
PHB knockdown. We speculate that p53 null cells with PHB
knockdown likely show more autophagy due to a combination of
ER stress-induced autophagy (due to p53 knockout) and
mitophagy (due to loss of PHB expression and p53 knockout).
In conclusion, we demonstrate that the mitochondrial protein
PHB modulates autophagy in intestinal epithelial cells via intracel-
lular ROS signaling. Decreased PHB expression coupled with
inhibition of autophagy, renders intestinal epithelial cells unable to
maintain cell homeostasis and susceptible to mitochondrial damage
and cytotoxicity. These findings have elucidated a molecular
pathway whereby increased ROS by decreased PHB may enhance
inflammation in patients with inflammatory bowel disease.
Materials and Methods
Cell culture
The Caco2-BBE human intestinal epithelial cell line was used as
in vitro model of polarized intestinal epithelium. The Caco2-BBE
cell line was obtained from the American Type Culture Collection
(ATCC; Manassas, VA). Since Caco2-BBE cells have mutated
p53, wild-type (WT) and p53 null [51] HCT116 human colonic
epithelial cells were utilized to assess the involvement of p53 in
autophagy induction by PHB knockdown. Cells were grown in
Dulbecco’s modified Eagle’s medium (DMEM; Caco2-BBE) or
Modified McCoy’s media (HCT116) supplemented with penicillin
(40 mg/l), streptomycin (90 mg/l), and 10% fetal bovine serum.
Caco2-BBE cells were plated on permeable supports to allow the
cells to polarize (pore size, 0.4 mm; transwell-clear polyester
membranes; Costas life science, Acton, MA), while HCT116 cells
were plated on plastic. All experiments performed on Caco2-BBE
cells were between passages 32 and 45.
PHB knockdown and overexpression
Cells were transiently transfected with Stealth RNAi
TM against
PHB1 (59-CAGAAUGUCAACAUCACACUGCGCA -39)o r
Stealth RNAi
TM siRNA Negative Control Med GC (Invitrogen,
Carlsbad, CA) at 20 mm concentration. Caco2-BBEs were
transfected using AmaxaH Cell Line Optimization NucleofectorH
Kit T (Lonza, Basel, Switzerland), while HCT116 were transfected
with LipofectAmine 2000 (Invitrogen). Cells were transfected with
siRNA for 96 hours (Figure S1A–D). For PHB overexpression
studies, Caco2-BBE cells were transiently transfected with either
pEGFPN1 expression vector (V) or pEGFPN1-PHB (P) for
72 hours (generation of the pEGFPN1-PHB construct is described
below).
Autophagy activation and inhibition
Serum deprived cells were treated with 10 ng/ml recombinant
human TNFa (R&D Systems, Minneapolis, MN) or 50 ng/ml
recombinant human IFNc (eBioscience, San Diego, CA) for
18 hours. When treating Caco2-BBE cells, TNFa was adminis-
tered to the basolateral chamber, while IFNc was administered to
the apical and basolateral chambers. To inhibit autophagy, cells
were treated with 100 nM Bafilomycin A1 (Baf A; Sigma-Aldrich,
St. Louis, MO) 24 h prior to collection or co-transfected with
20 mm siATG16L1 (59-AUUACUGCCAGAUAGGGAACC-
CUUG-39). Efficiency of siRNA knockdown was assessed by
Western blotting (Figure 5D). Cells were treated with 1.0 or
10.0 mM N-acetyl-L-cysteine (Sigma-Aldrich), a ROS scavenger,
for 24 hours prior to collection.
Generation of stably-transfected Caco2-BBE cell
expressing pEGFPN1-PHB
A single PHB PCR product corresponding to the entire coding
region of PHB (818 bp) was generated from Caco2-BBE cells using
an antisense primer with a mutated PHB stop codon, underlined
(59-AATTGGATCCCCTCCCTGGGGCAGCTGGA-39). The
PCR product was ligated into pEGFPN1 vector (Clontech, Palo
Alto, CA) using the Quick Ligation Kit (New England Biolabs,
Ipswich, MA) and sequenced. Caco2-BBE cells were transfected
with pEGFPN1-PHB or empty pEGFPN1 vector using Lipofecta-
mine 2000 (Invitrogen) and the transfected clones were selected
under 0.12% geneticin (Sigma-Aldrich), and fluorescent cells were
isolated using flow cytometry (fluorescence-activated cell sorting).
Western blot analysis
Total protein was collected from Caco2-BBE or HCT116 cells
in lysis buffer containing 1% Triton X-100, 1% Nonidet P-40
(vol/vol), 1 mM EDTA, 1 mM sodium orthovanadate, 1 mM
sodium fluoride, and 1 ml/ml mammalian protease inhibitor
cocktail (BioExpress, Kaysville, UT) to obtain total protein
extracts. The samples were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) using laemmli’s
26 SDS sample buffer and AnyKD
TM gradient polyacrylamide
gels (Bio-Rad, Hercules, CA) followed by electrotransfer to
nitrocellulose membranes (Bio-Rad). Membranes were incubated
with primary antibodies at 4uC overnight and subsequently
incubated with corresponding peroxidase-conjugated secondary
antibodies. Membranes were washed and immunoreactive pro-
teins were detected using Amersham ECL Plus
TM reagent (GE
Healthcare, Piscataway, NJ). Blots were reprobed with anti-b-actin
(Sigma-Aldrich) antibody. Mouse monoclonal PHB antibody was
obtained from Thermo Fisher (Fremont, CA), mouse monoclonal
GFP, mouse monoclonal ClpP, and rabbit polyclonal PKR
antibodies from Santa Cruz Biotechnology (Santa Cruz, CA),
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Aldrich, rabbit polyclonal Beclin-1, cleaved Caspase- 3, p53,
Cpn60, and all ER stress antibodies from Cell Signaling
Technology (Danvers, MA).
Fluorescence microscopy
pSelect-NGFP-LC3 was purchased from InvivoGen (San Diego,
CA). pSelect-GFP-LC3 was co-transfected into Caco2-BBE and
HCT116 cells with either siNeg Ctl or siPHB for 96 hours. Cells
were fixed in buffered 4% paraformaldehyde for 20 minutes,
washed with phosphate buffered saline, and counterstained with
DAPI to visualize nuclei. Stained cells were mounted in
phenylenediamine/glycerol (1:1) and analyzed by fluorescence
microscopy (Zeiss Axioskope Plus).
Confocal microscopy
Caco2-BBE cells grown to confluency on filters were transfected
with pSelect-NGFP-LC3 for 96 hours and incubated with 100 nM
MitoTracker dye (Invitrogen) for 15 minutes. A subset of cells was
treated with 1.0 mM NAC for 24 hours prior to collection. Cells
were fixed in buffered 4% paraformaldehyde for 20 minutes,
washed with PBS, and counterstained with DAPI to visualize
nuclei. Samples were mounted in p-phenylenediamine/glycerol
(1:1) and analyzed by confocal microscopy.
DCF assay
As a measure of intracellular ROS, conversion of the nonionic,
nonpolar 29,7 9 –dichlorodihydrofluorescein diacetate (H2DCFDA:
Invitrogen) to fluorescent 29,7 9 –dichlorofluorescein (DCF) was
measured. Caco2-BBE cells were loaded with 10 mMH 2DCFDA
for 10 minutes and fluorescence was quantitated 10, 20 and
30 minutes later according to the manufacturer’s protocol using a
plate reader.
Cytotoxicity test
Lactate dehydrogenase (LDH) cytotoxicity detection kit (Clon-
tech, Mountain View, CA) was used to measure cell viability. LDH
determines the secretion of LDH into the culture medium from
dead or membrane-damaged cells. Caco2-BBE cells transfected
with siRNA for 96 hours and were treated with TNFa, IFNc,o r
Baf A alone or in combination for 18 hours prior to collection. An
aliquot of 100 ml of culture media was added to 100 ml of LDH
reagent and % cytotoxicity and % viable cells were measured
according to the manufacturer’s protocol using a plate reader.
Terminal deoxynucleotidyl transferase-mediated
deoxyuridine triphosphate nick-end labeling (TUNEL)
staining
TUNEL staining was performed on confluent Caco2-BBE cells
as described by the manufacturer’s protocol (Roche, Indianapolis,
IN).
FACS analysis of mitochondrial membrane potential
Mitoprobe
TM JC-1 assay kit was used (Molecular Probes,
Eugene, OR) to detect mitochondrial membrane depolarization.
JC-1 is a cationic dye which gives orange emission upon
aggregates in normal polarized mitochondria and in monomeric
form gives green fluorescence in the depolarized mitochondria.
Briefly, 4610
5 Caco2-BBE cells transfected with siNeg Ctl or
siPHB for 96 hours were trypsinized, washed and resuspended in a
final volume of 1 ml of warm media. Cells were stained with 2 mm
JC-1 dye for 15 minutes at 37uC protected from light. After
incubation, cells were washed and resuspended in 500 mlo f
phosphate buffered saline and were analyzed on Becton Dickinson
FACS Canto II flow cytometer.
Statistical analysis
Values are expressed as mean 6 SEM. Comparisons between
TNFa or IFNc treatment or siPHB versus control were analyzed
by unpaired Student’s t-test. Comparisons between PHB RNAi
and autophagy inhibition were analyzed by two-way analysis of
variance to test for a significant interaction between PHB
knockdown and impaired autophagy. Subsequent pair wise
comparisons used Bonferroni post-hoc tests to test for significant
differences between two particular groups. p,0.05 was considered
statistically significant in all analyses.
Supporting Information
Figure S1 PHB knockdown does not induce a mitochon-
drial unfolded protein response in Caco2-BBE cells.
Representative Western blot showing expression of the mitochon-
drial stress proteins Cpn60, PKR, ClpP. PHB protein levels were
assessed to determine efficiency of knockdown.
(TIF)
Figure S2 ER stress markers are not further increased
in p53-null HCT116 cells upon PHB knockdown. Repre-
sentative Western blots showing expression of various ER stess
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